There was a trend toward a higher number of follicular DCs (CD21+) in the peribronchial lymphoid tissue of COPD patients compared with non-COPD subjects (22.2% versus 15.8%, respectively), although the difference failed to reach statistical significance (Fig 3A). This evidence concerns the gene CR2 and chronic obstructive pulmonary disease.